-
Angiotech Pharmaceuticals (Vancouver, British Columbia) reported expiration of the FTC's waiting period for its purchase of American Medical Systems Holdings (AMI; Lake Forest, Illinois), allowing it to proceed with the $785 million all-cash acquisition, subject to satisfying remaining conditions.
-
MicroMed Cardiovascular (Houston), which is focused on the development of miniaturized implantable ventricular assist technology, said it has initiated a multicenter evaluation of its newest design of the DeBakey VAD (ventricular assist device).
-
Guidant (Indianapolis) and its Cardiac Rhythm Management (CRM) business do not have a process for comprehensive internal or external medical review of the clinical impact of product malfunction.
-
This year's annual scientific sessions of the American College of Cardiology (ACC; Bethesda, Maryland), held here in early March, included a newly launched meeting-within-a meeting focusing on interventional cardiology, a change that is indicative of the growing importance of device-based therapies in cardiovascular disease. Drug-eluting stents (DES) continue to play a key role in market expansion, and now dominate the field of percutaneous intervention (PCI) in the U.S. and, increasingly, in Europe.
-
The most recent Sentinel Event Alert issued by the Joint Commission on the Accreditation of Healthcare Organizations addresses medication reconciliation and the importance of this process in reducing the risk of medication errors.
-
For the first time since 1996, the Centers for Disease Control and Prevention (CDC) will conduct the National Survey of Ambulatory Surgery (NSAS).
-
The next time you need to purchase a laser, how would you like to pay $8,000 for a used one instead of $30,000 or $50,000-$100,000 to purchase a new one? Those were the options faced by one ophthalmologist who turned to the Internet when he needed a CO2 laser.
-
-
Four times a year, staff and board members from IRBs around the St. Louis area get together to talk about the issues that concern them, in an effort to learn from each other and to jointly sponsor educational programs.
-
The software demands of smaller IRBs and larger ones can be very different, and its hard to meet everybodys needs with a single program. So Third Sky Inc. doesnt try.